Fisher & Paykel Healthcare Corp. Ltd. engages in the designing, manufacturing and marketing of medical device products and systems for use in respiratory care, acute care and the treatment of obstructive sleep apnea. It operates through the following segments: The New Zealand, North America, Europe, and Asia-Pacific. New Zealand segment includes all activities controlled by entities or employees based in New Zealand, principally research and development, manufacturing, marketing, sales and distribution and administration. The North America segment refers to all activities controlled by entities or employees based in the United States of America and Canada, principally sales, distribution and administration activities. The Europe segment includes all activities controlled by entities or employees based in the United Kingdom, France, Germany, Sweden, Turkey and Russia, principally sales, distribution and administration activities. The Asia-Pacific segment refers to all activities controlled by entities or employees based in Australia, Japan, India, China, South Korea, Taiwan and Hong Kong, principally sales, distribution and administration activities. The company was founded in 1934 and is headquartered in Auckland, New Zealand.